GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT) » Definitions » Equity-to-Asset

Sartorius AG (XTER:SRT) Equity-to-Asset : 0.25 (As of Mar. 2024)


View and export this data going back to 1990. Start your Free Trial

What is Sartorius AG Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Sartorius AG's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €2,672 Mil. Sartorius AG's Total Assets for the quarter that ended in Mar. 2024 was €10,628 Mil. Therefore, Sartorius AG's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.25.

The historical rank and industry rank for Sartorius AG's Equity-to-Asset or its related term are showing as below:

XTER:SRT' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.21   Med: 0.27   Max: 0.36
Current: 0.25

During the past 13 years, the highest Equity to Asset Ratio of Sartorius AG was 0.36. The lowest was 0.21. And the median was 0.27.

XTER:SRT's Equity-to-Asset is ranked worse than
87.33% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs XTER:SRT: 0.25

Sartorius AG Equity-to-Asset Historical Data

The historical data trend for Sartorius AG's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Equity-to-Asset Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.23 0.22 0.29 0.21

Sartorius AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.29 0.21 0.21 0.25

Competitive Comparison of Sartorius AG's Equity-to-Asset

For the Medical Instruments & Supplies subindustry, Sartorius AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Equity-to-Asset falls into.



Sartorius AG Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Sartorius AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=2067.3/9755.3
=0.21

Sartorius AG's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=2671.5/10627.8
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sartorius AG  (XTER:SRT) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Sartorius AG Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG (XTER:SRT) Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.